IRIS PubliCatt

Sica, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.913
EU - Europa 7.751
AS - Asia 1.878
SA - Sud America 105
OC - Oceania 96
AF - Africa 87
Continente sconosciuto - Info sul continente non disponibili 11
Totale 18.841
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.783
DE - Germania 2.176
SE - Svezia 1.622
IT - Italia 1.251
CN - Cina 1.156
IE - Irlanda 573
UA - Ucraina 526
FR - Francia 457
GB - Regno Unito 409
IN - India 222
FI - Finlandia 189
ES - Italia 145
CA - Canada 97
TR - Turchia 96
AU - Australia 87
JP - Giappone 80
SG - Singapore 71
PL - Polonia 69
BR - Brasile 55
CI - Costa d'Avorio 55
IR - Iran 54
HK - Hong Kong 51
BE - Belgio 45
RU - Federazione Russa 38
NL - Olanda 37
RO - Romania 29
MX - Messico 25
AR - Argentina 23
ID - Indonesia 22
CZ - Repubblica Ceca 19
KR - Corea 19
PT - Portogallo 19
AT - Austria 18
CH - Svizzera 18
HU - Ungheria 16
EG - Egitto 15
GR - Grecia 15
NO - Norvegia 15
VN - Vietnam 15
IL - Israele 14
SK - Slovacchia (Repubblica Slovacca) 10
TW - Taiwan 10
BG - Bulgaria 9
NZ - Nuova Zelanda 9
TH - Thailandia 9
CO - Colombia 8
RS - Serbia 8
CL - Cile 7
MY - Malesia 7
PH - Filippine 7
BZ - Belize 6
EU - Europa 6
HR - Croazia 6
PK - Pakistan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AE - Emirati Arabi Uniti 5
LB - Libano 5
NP - Nepal 5
PE - Perù 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
BA - Bosnia-Erzegovina 4
DK - Danimarca 4
DZ - Algeria 4
EC - Ecuador 4
LT - Lituania 4
MD - Moldavia 4
BY - Bielorussia 3
EE - Estonia 3
IQ - Iraq 3
LI - Liechtenstein 3
MA - Marocco 3
BD - Bangladesh 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LU - Lussemburgo 2
QA - Qatar 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
UZ - Uzbekistan 2
BO - Bolivia 1
CY - Cipro 1
IS - Islanda 1
LV - Lettonia 1
MC - Monaco 1
MK - Macedonia 1
MT - Malta 1
PS - Palestinian Territory 1
SC - Seychelles 1
Totale 18.841
Salva come PNG Salva come JPEG
Città #
Chandler 1.551
Ashburn 762
Dublin 564
Jacksonville 405
San Mateo 370
Dearborn 304
Wilmington 303
Woodbridge 272
Ann Arbor 267
Milan 258
Nanjing 254
Houston 206
Beijing 205
Redwood City 198
Boston 191
Princeton 191
Cattolica 174
Fairfield 161
Seattle 150
New York 133
Lancaster 131
Nürnberg 130
Lawrence 118
Redmond 112
Oviedo 111
Rome 111
Marseille 110
Nanchang 110
Bremen 84
Hangzhou 84
Los Angeles 84
Izmir 68
Munich 66
Norwalk 62
Boardman 61
Chicago 61
Mountain View 57
Abidjan 55
Warsaw 54
Kunming 48
Cambridge 47
Hebei 47
Helsinki 43
Florence 42
Brussels 41
Shenyang 41
Tianjin 38
Zhengzhou 37
Pune 36
Hefei 34
Busto Arsizio 33
Hong Kong 33
Auburn Hills 31
Changsha 31
Jiaxing 30
London 29
Leawood 28
Washington 28
Guangzhou 26
Toronto 26
Singapore 25
University Park 23
Augusta 21
Brisbane 21
Shanghai 21
Philadelphia 20
Brooklyn 18
Buffalo 18
Phoenix 18
San Francisco 18
Buenos Aires 17
Rochester 17
São Paulo 17
Jinan 16
Naples 16
Tokyo 16
Bologna 15
Frankfurt am Main 14
Hanoi 14
Lanzhou 14
Falls Church 13
Fremont 13
Padova 13
Tehran 13
Atlanta 12
Hyderabad 12
Kyoto 12
Lappeenranta 12
San Diego 12
Sydney 12
Chengdu 11
Melbourne 11
Ottawa 11
Turin 11
Amsterdam 10
Andover 10
Berlin 10
Casale Monferrato 10
Changchun 10
Dallas 10
Totale 9.924
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 1.552
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 346
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 295
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 279
Dasatinib first-line: Multicentric Italian experience outside clinical trials 260
Dasatinib first-line: Multicentric Italian experience outside clinical trials 259
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 221
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 159
Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs 147
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 143
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 139
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 139
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 135
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 133
Correlation between paraproteinaemia and viral reactivation after allo-SCT 131
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 129
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 127
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 127
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 127
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 127
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 126
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 122
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 121
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 119
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 116
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 114
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 114
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 111
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation. 111
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 110
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 107
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 107
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 105
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 105
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 101
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 101
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 99
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 99
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 99
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 98
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 98
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 98
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (Gitmo) 98
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 97
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 97
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 96
Work related acute leukemia and mucor mycosis in a boat-builder 95
The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia. Leukemia. 95
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 95
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 95
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 94
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 93
Hyperleukocytosis and leukostasis: management of a medical emergency 93
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 91
Hyperleukocytosis and leukostasis: management of a medical emergency 91
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 91
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 88
Neurologic improvement after peripheral blood stem cell transplantation in poems 88
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 87
Autologus stem cell transplantation as bridging rherapy followed by CD19 Car-T cells in relapsed refractory large B cell lymphoma 87
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 86
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 86
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 85
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 85
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 83
Clonal evolution in therapy-related neoplasms 82
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 81
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 80
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 80
MTHFR polymorphisms involved in vitamin B12 deficiency associated with atrophic gastritis 79
Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome 78
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 78
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 76
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 75
Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomes 75
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 75
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 74
Molecular characterization of adenovirus from clinical samples through analysis of the hexon and fiber genes 73
Drug resistance and BCR-ABL kinase domain mutations in philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement 72
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy 72
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 72
Molecular characterization of adenovirus from clinical samples through analysis of the hexon and fiber genes 71
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 71
Alternative donor transplants for severe aplastic anemia: current experience 70
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 70
Blinatumomab as a successful and safe therapyin Down syndrome patients with relapsed / refractory b-precursor acute lymphoblastic leukemia: Case report and literature review 70
Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL 69
SARS-COV-2 vaccination in patients with paroxysmal nocturnal hemoglobinuria an italian multicenter survey 68
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study 67
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 66
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 65
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 65
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 65
Changes in protein serum levels during stem cell transplantation 64
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 63
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 63
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 62
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 62
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 62
Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival 61
Totale 11.928
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.415
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019241 0 0 0 0 0 0 0 0 0 0 158 83
2019/20202.627 436 200 174 156 228 266 230 131 147 209 274 176
2020/20212.211 435 239 76 125 184 109 139 62 292 90 386 74
2021/20222.639 249 128 79 139 163 78 66 392 141 179 510 515
2022/20235.141 753 662 414 713 371 621 258 338 570 170 180 91
2023/20243.013 121 829 176 190 211 540 221 153 165 249 158 0
Totale 19.340